Skip to content

Snacktivity™ intervention to promote physical activity during pregnancy

A randomised controlled trial to investigate the feasibility and acceptability of Snacktivity™ in pregnant women

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN60667435
Enrollment
90
Registered
2023-05-31
Start date
2023-07-21
Completion date
Unknown
Last updated
2023-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reproductive health and childbirth Pregnancy and Childbirth

Interventions

Participants will be randomised to receive either standard physical activity advice during pregnancy or encouragement to achieve the recommended physical activity levels for pregnancy via Snacktivity™
however, steps, light-to-vigorous physical activity, moderate-to-vigorous physical activity, and activity snacks will be monitored for the intervention group throughout the 24-week intervention period

Sponsors

Loughborough University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Pregnant women > = 18 years between 10 and 16+0 weeks gestation 2. Singleton pregnancy confirmed at early foetal scan 3. Able to speak and read standard English 4. Able to provide informed written consent 5. Access to an email address 6. Access to a smartphone with Bluetooth capable of hosting mobile applications (Apple iOS 10.0+ and Android OS 4.0+) 7. Complete < = 150 minutes of physical activity per week pre-pregnancy (as measured by the Exercise vital signs (EVS))

Exclusion criteria

Exclusion criteria: 1. Post-natal or non-pregnant women 2. Pregnant women past 16 weeks gestation 3. Severe sickness (hyperemesis gravidarum) 4. Currently taking part in a different research study that involves physical activity or other lifestyle behaviours 5. BMI >50 kg/m2 6. Inability or unwillingness to provide consent 7. Women whose GPs feel it is inappropriate for them to take part 8. Cannot speak and read standard English 9. No access to an email address 10. No access to a smartphone with Bluetooth capability for hosting mobile applications (Apple iOS 10.0+ and Android OS 4.0+) 11. Complete > 150 minutes of physical activity per week pre-pregnancy (as measured by the EVS)

Design outcomes

Primary

MeasureTime frame
The feasibility of a subsequent phase III randomised controlled trial (RCT) according to pre-specified progression criteria will be assessed at the final follow-up. The researchers are primarily interested in whether: 1. The trial is appealing measured using the number/percentage of people randomised against the recruitment target of 90 participants 2. The Snacktivity™ intervention is acceptable through assessing Snacktivity™ adherence measured using a physical activity tracker (Fitbit watch) and SnackApp data 3. Participant attrition measured using loss to follow-up in [the study notes] The feasibility and acceptability will also be assessed with participant interviews (intervention group only) and healthcare practitioner interviews on the indicators after the final follow-up: 1. Intervention delivery 2. Participant satisfaction, enjoyment, and intervention acceptability 3. Intervention sustainability

Secondary

MeasureTime frame
1. Total physical activity (light-to-vigorous activity and steps per day) measured using a research-grade wrist-worn accelerometer at baseline and 36 weeks gestation 2. Moderate-to-vigorous physical activity measured using a research-grade wrist-worn accelerometer at baseline and 36 weeks gestation 3. Sedentary time measured using a research-grade wrist-worn accelerometer at baseline and 36 weeks gestation 4. Gestational weight gain measured at baseline and 36 weeks gestation 5. Depression measured using the Edinburgh Postnatal Depression Scale at baseline, 26- and 36 weeks gestation 6. Fatigue measured using the Multidimensional Assessment of Fatigue at baseline, 26- and 36 weeks gestation

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026